Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.2.1.1 (
ACS
)
78,556
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Herein, we use linker fragmentation approach to introduce boronic acid moieties as functional defects into Zr-based metal-organic frameworks (MOFs, UiO-66). Our findings show that the amount of permanently incorporated boronic acid containing ligand is directly dependent on the synthesis method. The accessible boronic acid moieties in the pore surfaces significantly improve the hydrogen uptake values, which are 3.10 and 3.44 wt % at 21 bar, 77 K for dimethylformamide (DMF)/H
2
O and DMF/
HCI
synthesis methods, respectively. Also, CO
2
selectivity of the resulting MOFs over N
2
and CH
4
significantly increases due to the quadrupolar interaction between active surfaces and CO
2
molecules. To the best of our knowledge, both hydrogen storage and selectivity of CO
2
for UiO-66 are the highest reported values in the literature to date. Furthermore, another striking result that emerged from the high-pressure hydrogen uptake isotherms is the direct correlation between the defects and hysteric adsorption behavior, which may result in the shift from rigidity to flexibility of the framework due to the uncoordinated sites.
ACS
Appl Mater Interfaces 2018 Jan 10
PMID:Boronic Acid Moiety as Functional Defect in UiO-66 and Its Effect on Hydrogen Uptake Capacity and Selective CO
2
Adsorption: A Comparative Study. 2925 84
